Ally Bridge Group leads $300 mln round for GRAIL
GRAIL Inc, a healthcare company focused on detecting cancer early, has secured $300 million in Series C funding. The lead investor was Ally Bridge Group.
22 May 2018•1 min read
GRAIL Inc, a healthcare company focused on detecting cancer early, has secured $300 million in Series C funding. The lead investor was Ally Bridge Group.
